Risk prediction of incident coronary heart disease in The Netherlands: re-estimation and improvement of the SCORE risk function

Eur J Prev Cardiol. 2012 Aug;19(4):840-8. doi: 10.1177/1741826711410256. Epub 2011 May 6.

Abstract

Aims: To re-estimate the SCORE risk function using individual data on risk factors and coronary heart disease (CHD) incidence from the Dutch Cardiovascular Registry Maastricht (CAREMA) population-based cohort study; to evaluate changes that may improve risk prediction after re-estimation; and to compare the performance of the resulting CAREMA risk function with that of existing risk scores.

Methods and results: The cohort consisted of 21,148 participants, born in 1927-1977 and randomly sampled from the Maastricht region in 1987-1997. After follow-up (median 10.9 years), 783 incident CHD cases occurred. Model performance was assessed by discrimination and calibration. The additional value of including other risk factors or current risk factors in a different manner was evaluated using the net reclassification index (NRI). The c statistic of the re-estimated SCORE model was 0.799 (95% CI 0.782-0.816). Separating the total/high-density lipoprotein (HDL) cholesterol ratio into total and HDL cholesterol levels did not improve the c statistic (p = 0.22), but reclassified 6.0% of the participants into a more appropriate risk category (p < 0.001) compared with the re-estimated model. The resulting CAREMA function reclassified 28% of the participants into a more appropriate risk category than the Framingham score. Compared with the SCORE functions for high- and low-risk regions, the NRIs were 28% and 35%, respectively, which can largely be explained by the difference in outcome definition (CHD incidence vs. CHD mortality).

Conclusion: In this Dutch population, a re-estimated SCORE function with total and HDL cholesterol levels instead of the cholesterol ratio can be used for the risk prediction of CHD incidence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Blood Pressure
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Coronary Disease / blood
  • Coronary Disease / diagnosis
  • Coronary Disease / epidemiology*
  • Coronary Disease / physiopathology
  • Discriminant Analysis
  • Female
  • Humans
  • Incidence
  • Kaplan-Meier Estimate
  • Life Style
  • Linear Models
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Prospective Studies
  • Registries
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Young Adult

Substances

  • Biomarkers
  • Cholesterol, HDL
  • Cholesterol